Inventor · disambiguated record
Ivan B. Lobov
Also filed as: LOBOV IVAN B · LOBOV IVAN BORISOVICH
12 granted patents·4 pending applications·119 citations·filing 2003–2023
89Inventor score
Top patents by PatentIndex Score
16 records- 0197US9265827B2Anti-PDGFR-beta antibodies and uses thereofREGENERON PHARMA·Filed 2014·Granted Feb 23, 2016·87 cites·6 claims
- 0293US9644018B2Antibody modulators of APLNRREGENERON PHARMA·Filed 2015·Granted May 9, 2017·13 cites·11 claims
- 0392US9650444B2Anti-PDGFR-beta antibodies and uses thereofREGENERON PHARMA·Filed 2016·Granted May 16, 2017·12 cites·17 claims
- 0487US10626173B2Method for treating pathological angiogenesis by administering an antibody that inhibits APLNRREGENERON PHARMA·Filed 2018·Granted Apr 21, 2020·2 cites·20 claims
- 0583US2024091301A1APLNR Modulators and Uses ThereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0682US10947310B2Fusion protein comprising apelin and an anti-APLNR antibodyREGENERON PHARMA·Filed 2018·Granted Mar 16, 2021·1 cites·20 claims
- 0782US10189901B2Methods for improving cardiac function by administering an antibody that activates APLNRREGENERON PHARMA·Filed 2017·Granted Jan 29, 2019·2 cites·13 claims
- 0879US10155811B2APLNR modulators and uses thereofREGENERON PHARMA·Filed 2014·Granted Dec 18, 2018·2 cites·20 claims
- 0975US11642390B2Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibodyREGENERON PHARMA·Filed 2021·Granted May 9, 2023·0 cites·18 claims
- 1066US11071780B2Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumabREGENERON PHARMA·Filed 2018·Granted Jul 27, 2021·0 cites·9 claims
- 1159US7488573B2In vivo angiogenesis assayCHILDRENS HOSP MEDICAL CENTER·Filed 2003·Granted Feb 10, 2009·0 cites·18 claims
- 1257US10023642B2Anti-PDGFR-beta antibodies and uses thereofREGENERON PHARMA·Filed 2017·Granted Jul 17, 2018·0 cites·4 claims
- 1349US2017080086A1Methods and formulations for treating vascular eye diseasesREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 1447US2008181893A1Therapeutic methods for treating vascular eye disorders with DII4 antagonistsLOBOV IVAN B·Filed 2007·Application pending·0 cites
- 1546US2016144025A1Methods and formulations for treating vascular eye diseasesREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1645US11104730B2Methods of treating eye disorders with APLNR antagonists and VEGF inhibitorsREGENERON PHARMA·Filed 2018·Granted Aug 31, 2021·0 cites·46 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →